Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy

Part of paid clinical trials in Boise, Idaho.

Sponsor
Summit Hyperbarics and Wellness
Study ID
NCT07214415
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • PTSD - Post Traumatic Stress Disorder
  • Post Concussive Syndrome
  • TBI Traumatic Brain Injury

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Hyperbaric Oxygen Therapy — DRUG
    Each HBOT session is scheduled for approximately 95 minutes. The session will begin with a descent of up to 15 minutes (longer if needed for comfort/safety) to a pressure of 2.0 ATA, followed by 30 minutes of breathing 100% oxygen. At the midpoint, there will be a 5-minute air break from oxygen, after which subjects resume breathing 100% oxygen for another 30 minutes. Finally, the session will conclude with an ascent of up to 15 minutes (longer if needed for comfort/safety) back to 1.0 ATA. All sessions are delivered under direct medical supervision with standardized safety protocols. Once approved after medical and behavioral screening, participants complete a battery of cognitive, mental health, and quality of life assessments at baseline (pre-) and after completing the therapy (post-). This arm is distinct from any sham or control interventions because all participants receive the active HBOT treatment.

Study Details

The purpose of this study is to evaluate how hyperbaric oxygen therapy (HBOT) may affect cognitive functioning, post-traumatic stress disorder (PTSD), depression, anxiety, and overall quality of life in veterans. 1. Does Hyperbaric Oxygen Therapy improve cognitive functioning, psychological well-being, and quality of life among veterans, as measured by pre-and post-treatment scores? 2. To what extent does Hyperbaric Oxygen Therapy improve cognitive functioning, psychological well-being, and qualify of life among veterans, after controlling for demographic characteristics.

Key Dates

Start date
Oct 1, 2025
Status verified
Sep 2025
Primary completion
Sep 15, 2026
Completion
Sep 15, 2026

Study Design

Enrollment
54 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: HBOT Intervention Group

Primary Outcome Measure

PTSD Checklist for DSM-5 (PCL-5) [ Time Frame: From baseline assessment prior to first HBOT session to immediately after completion of final HBOT session ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Summit Hyperbarics and WellnessBoiseIdaho83716
Troy Nickel, PhD
[email protected]
208-813-9541

Find similar trials in Boise, ID

By research site
Summit Hyperbarics and Wellness· Boise, ID

Related Studies